Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05117671
Other study ID # 2021-00133; mu21Clauss
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 16, 2021
Est. completion date October 19, 2021

Study information

Verified date February 2024
Source University Hospital, Basel, Switzerland
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This retrospective multi-center, multi-national cohort study is to validate the European Bone and Joint Infection Society (EBJIS) Definition of Prosthetic Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and compare it to the Infection Unlikely group as well as other subgroups within previous validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal Infection (ICM) 2013 and ICM 2018).


Description:

Periprosthetic joint infection (PJI) is a major burden for healthcare systems. The European Bone and Joint Infection Society (EBJIS) proposed a new set of criteria introducing a three level 'traffic light' distinction: Infection Unlikely, Infection Confirmed but also an intermediate group called Infection Likely (but nor confirmed). This retrospective multi-center, multi-national cohort study is to validate the EBJIS Definition of Prosthetic Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and compare it to the Infection Unlikely group as well as other subgroups within previous validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal Infection (ICM) 2013 and ICM 2018).


Recruitment information / eligibility

Status Completed
Enrollment 1554
Est. completion date October 19, 2021
Est. primary completion date August 16, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - THA/TKA patients that underwent revision surgery regardless of final aseptic vs. infected diagnosis between 01.01.2013 until 31.12.2018 Exclusion Criteria: - less than two years follow up - less than four intraoperative microbiology samples (synovial fluid, tissue samples, implant sonication) - no preoperative/intraoperative synovial fluid differential leukocyte count

Study Design


Related Conditions & MeSH terms


Intervention

Other:
data collection to classify infection status
Review of medical records of all selected cases (TKA/THA patients) to classify infection status according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).

Locations

Country Name City State
Portugal Centro Hospitalar do Porto, Porto, Portugal Porto
Switzerland University Hospital Basel, Orthopedics and Traumatology Basel

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Basel, Switzerland

Countries where clinical trial is conducted

Portugal,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prosthetic Joint Infections (with or without the need for further surgery) Number of Prosthetic Joint Infections (with or without the need for further surgery) among each PJI definition ("Infection Unlikely", "Infection Confirmed", "Infection Likely (but nor confirmed)" since 01.01.2013 with a minimum of two years follow up
Primary Prosthetic Joint Infections (with or without the need for further surgery) Number of Prosthetic Joint Infections (with or without the need for further surgery) according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018). since 01.01.2013 with a minimum of two years follow up
Primary Need for Revision Surgery Number of Revision Surgeries (for all causes, PJI and aseptic failure) among each PJI definition ("Infection Unlikely", "Infection Confirmed", "Infection Likely (but nor confirmed)" since 01.01.2013 with a minimum of two years follow up
Primary Need for Revision Surgery Number of Revision Surgeries (for all causes, PJI and aseptic failure) according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018). since 01.01.2013 with a minimum of two years follow up
Primary Survival rates of different subgroups among each PJI definition Survival rates of different subgroups among each PJI definition ("Infection Unlikely", "Infection Confirmed", "Infection Likely (but nor confirmed)" since 01.01.2013 with a minimum of two years follow up
Primary Survival rates between different definitions Survival rates between different classifications (EBJIS, MSIS/ICM 2013, ICM 2018). since 01.01.2013 with a minimum of two years follow up
See also
  Status Clinical Trial Phase
Terminated NCT04583241 - Prospective Study of Patients Treated for Bone and Joint Infection (BJI) Due to Staphylococcus Aureus, Aiming at Identifying Biomarkers of Diagnosis Interest in Chronic BJI